EN
Be the global leader of T cell cancer immunotherapy
 
Management Team
  • Qi-Jing Li
    Qi-Jing Li
    Ph.D., Co-founder
    Expert in TCR antigen recognition, T cell function; participated in China's first CD19 CAR-T IND.
  •  Pin Wang
    Pin Wang
    Ph.D., Co-founder
    Expert in immuno-engineering, viral manufacturing; Scientific founder of Immune Design (acquired by Merk).
  • Frank Su
    Frank Su
    M.D., MBA, Co-founder
    Veteran entrepreneur, biotech investor;
    Extensive clinical development, BD experience.
  • Wei-Wu He
    Wei-Wu He
    Ph.D., MBA, Co-founder
    25+ years industry experience; 20+ years in VC;
    Founder of >20 biotechs, with strong focus on bioinformatics, data-driven therapy.
  • Si Li
    Si Li
    Ph.D., CTO
    Cancer immunologist with specialization in cell engineering, gene therapy, and virology.
  • Qin Yun
    Qin Yun
    M.D.,CMO-China
    Rich experience in clinical development.
    Has worked in several multinational and innovative pharmaceutical companies (MSD, Pfizer, AstraZeneca, and JW Therapeutics)
  • Xuejie Xu
    Xuejie Xu
    Manufacturing VP
    Extensive expertise in cellmanufacturing, technology transfer, quality control, and commercialization.
    Led manufacturing processes at multiple innovative biopharmaceutical companies, including Legend Biotech, Celgen Biopharm, Kehua Biotech, and Anke Biotech.
  • Li-Feng Zhang
    Li-Feng Zhang
    Ph.D., R&D Director, PI Head
    18+ years research experience with deep expertise in cell biology and cell therapy.
  • Ling Peng
    Ling Peng
    M.D.,Ph.D., Medical Director
    15 years of clinical oncologist;
    Rich experience in tumor immunotherapy.

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer